Welcome to our dedicated page for Surgery Partners news (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.
Surgery Partners, Inc. (NASDAQ: SGRY) is a healthcare services company headquartered in Brentwood, Tennessee, focused on short-stay and outpatient surgical care. News about Surgery Partners often centers on its performance as a short-stay surgical facility owner and operator, its financing activities, and developments across its network of ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
Investors following SGRY news can expect regular quarterly earnings announcements that discuss revenue growth, same-facility revenues, case volumes, Adjusted EBITDA and liquidity. These releases frequently include guidance ranges for full-year revenues and Adjusted EBITDA, along with commentary from management on operational execution, portfolio performance and the company’s long-term growth approach.
In addition to earnings, Surgery Partners’ news flow includes updates on capital structure and debt financing. Recent items have described the issuance and pricing of 7.250% senior unsecured notes due 2032 through its subsidiary, Surgery Center Holdings, Inc., as well as amendments to its credit agreement that introduce refinancing term loans and revolving credit commitments. These developments are relevant for understanding the company’s funding strategy and leverage profile.
Strategic and partnership news is another key theme. For example, Surgery Partners has announced a joint venture with Baylor Scott & White Health to jointly own a 16-bed hospital in Bryan, Texas, known as The Physicians Centre Hospital. This facility offers a broad range of surgical services, including bariatric, orthopedic, ophthalmologic, gastroenterological, podiatric, spinal and urologic procedures, along with general, plastic and reconstructive surgery, sports medicine, pain management and radiology services.
Governance and leadership updates, such as changes in board roles, executive appointments and resignations, are also disclosed through news releases and Form 8-K filings. For ongoing insight into SGRY, this news page aggregates company-issued announcements, financial updates and material events reported to the SEC.
Summary not available.
Surgery Partners (NASDAQ:SGRY) will release its first quarter 2023 results on May 1, 2023, after market close. A conference call is scheduled for the same day at 5:00 p.m. ET. Interested parties can participate via a dial-in number or by accessing a live webcast on the Company's Investor Relations website. Surgery Partners is a prominent healthcare services provider, specializing in outpatient surgical care with over 180 locations across 31 states. The company aims to deliver high-quality, cost-effective solutions in surgical and related ancillary care.
Surgery Partners (SGRY) reported a revenue increase of 15.9% to $707.1 million for Q4 2022 and 14.1% to $2.5 billion for the full year. Despite strong revenue growth, the company faced a net loss of $23.4 million for Q4 2022 and $54.6 million for the full year. Adjusted EBITDA rose by 5.6% to $120.8 million in Q4 and 12.0% to $380.2 million for the full year. The company anticipates 2023 revenues greater than $2.75 billion and Adjusted EBITDA exceeding $425 million.
Surgery Partners, Inc. (NASDAQ:SGRY) announced that it will release its fourth quarter 2022 results on March 1, 2023, before the market opens. A conference call will follow at 8:30 a.m. ET, where investors can access the live call by dialing 1-877-451-6152 for domestic calls and 1-201-389-0879 for international attendees. A replay will be available after the call until March 15, 2023. Surgery Partners is a prominent name in the healthcare sector, operating over 180 locations across 31 states. For more information, visit their website at www.surgerypartners.com.
Surgery Partners (NASDAQ:SGRY) is reaffirming its 2022 financial guidance during the J.P. Morgan Healthcare Conference on January 9, 2023. The company projects an Adjusted EBITDA of $375 million to $385 million and revenue of $2.50 billion to $2.55 billion. Headquartered in Brentwood, TN, Surgery Partners operates over 180 locations across 31 states, focusing on high-quality, cost-effective surgical services. The company acknowledges risks including COVID-19 impacts, economic conditions, and potential delays in financial closing procedures, which may affect actual results.
Surgery Partners, Inc. (NASDAQ:SGRY), a prominent healthcare services provider, will present at the J.P. Morgan Healthcare Conference on January 9, 2023, at 8:15 PM ET. Key executives, including Wayne S. DeVeydt, Eric Evans, and Dave Doherty, will engage with investors during this event. A live webcast of the presentation is accessible via the company’s Investor Relations website, with a replay available afterward. Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners operates over 180 locations across 31 states, delivering high-quality surgical and ancillary care.
Surgery Partners (NASDAQ:SGRY) reported third-quarter 2022 revenue of $620.6 million, a rise of 11.0% year-over-year. Same-facility revenues grew by 5.1%. Despite a net loss of $25.0 million, Adjusted EBITDA increased by nearly 26% to $96.2 million, with margins at 15.5%. The company reaffirmed its 2022 Adjusted EBITDA projection of $375 million to $385 million, and revenue expectations between $2.5 billion and $2.55 billion. The results were influenced by Hurricane Ian's impact on Florida operations, but strong operational performance and continued acquisitions helped maintain growth.
Surgery Partners, Inc. (NASDAQ:SGRY) announced that it will release its third quarter 2022 results before the market opens on November 8, 2022. This will be followed by a conference call at 8:30 a.m. Eastern Time. Interested participants can join the call via a domestic dial-in number at 1-877-451-6152 or an international line at 1-201-389-0879. A replay will be available shortly after the call until November 22, 2022. Surgery Partners operates over 180 surgical facilities across 32 states, focusing on cost-effective surgical solutions for patients and physicians.
Physicians Realty Trust reported a second quarter 2022 net income of $0.07 per share and $0.27 Normalized FFO per share, with total revenue rising 17% to $132.2 million. The Trust executed $46.9 million in investments, announced a quarterly dividend of $0.23 per share, and disposed of one property for $6.4 million, realizing a net gain of $3.7 million. A significant sale of three facilities in Great Falls, Montana on July 14 generated $116.3 million with a net gain of $53.9 million. The portfolio was 95% leased, and Same-Store Cash NOI grew 1.9% year-over-year.
Surgery Partners (NASDAQ:SGRY) reported a 13.3% revenue increase to $615.4 million for Q2 2022, driven by 149,000 surgical cases performed, up nearly 7% year-over-year. Adjusted EBITDA rose 13.4% to $86.1 million, with margins at 14.0%. Despite a net loss of $18.4 million, the company reaffirmed its 2022 guidance for revenue between $2.5 billion and $2.6 billion. Cash flow from operating activities surged to $42.1 million, significantly above last year's $2.3 million. The company maintains a strong liquidity position with $227.4 million in cash.